Naturally occurring decreased susceptibility of HIV-1 subtype G to protease inhibitors.
Descamps
D
D
Apetrei
C
C
Collin
G
G
Damond
F
F
Simon
F
F
Brun-Vézinet
F
F
D019380:Anti-HIV Agents / Q000494:pharmacology*; D015752:Genes, env; D015658:HIV Infections / Q000821:virology*; D017320:HIV Protease Inhibitors / Q000494:pharmacology*; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D019469:Indinavir / Q000494:pharmacology; D019438:Ritonavir / Q000494:pharmacology; D019258:Saquinavir / Q000494:pharmacology
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D019469:Indinavir; D019258:Saquinavir; D019438:Ritonavir